Enovis Corp Stock Fair Value – Thrivent Financial for Lutherans Invests $39.24 Million in Enovis Co. in 2023.
March 16, 2023
Trending News 🌥️
Thrivent Financial for Lutherans, a leading financial services provider, recently announced their investment of $39.24 million in Enovis ($NYSE:ENOV) Co., a software development and consulting company. This stake held by Thrivent Financial for Lutherans is the latest indication of their commitment to invest in successful tech companies. The investment marks a major milestone for Enovis Co., as it solidifies their presence in the competitive software development and consulting market. The infusion of funds will provide Enovis Co. with the necessary capital needed to expand their operations and reach. It will also help them to accelerate their growth and scale up their products and services. The investment is likely to have a positive impact on Enovis Co.’s financial performance as they capitalize on the financial resources provided by Thrivent Financial for Lutherans.
It will also help them to further strengthen their competitiveness in the market and expand their client base. The strategic partnership between Thrivent Financial for Lutherans and Enovis Co. marks an important moment for the future of both companies. This $39.24 million investment is expected to generate significant value and expand Enovis Co.’s reach into new markets and applications. It will also position them well to take advantage of upcoming industry trends and opportunities.
Share Price
On Monday, ENOVIS CORP saw a slight downturn in stock prices as the opening price of $53.1 closed at $53.6, a decrease of 0.4% from its prior closing price of 53.8. This notable investment indicates a vote of confidence in the company and its future success. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Enovis Corp. More…
| Total Revenues | Net Income | Net Margin |
| 1.56k | -13.29 | -6.8% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Enovis Corp. More…
| Operations | Investing | Financing |
| -55.86 | -176.39 | -465.13 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Enovis Corp. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 4.27k | 823.45 | 63.58 |
Key Ratios Snapshot
Some of the financial key ratios for Enovis Corp are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -22.3% | -3.3% | 1.4% |
| FCF Margin | ROE | ROA |
| -10.3% | 0.4% | 0.3% |
Analysis – Enovis Corp Stock Fair Value
At GoodWhale, we have done a comprehensive analysis of ENOVIS CORP‘s fundamentals, and have come to the conclusion that the intrinsic value of their share is around $91.5. This value has been calculated using our proprietary Valuation Line, which takes into consideration a variety of factors such as the company’s financials, market sentiment and industry trends. This suggests that their stock is currently undervalued and may be a good investment opportunity for investors. More…
Peers
Enovis Corp, a leading provider of optoelectronic products and services, competes with Beyond Medical Technologies Inc, Hefei Meyer Optoelectronic Technology Inc, and Optorun Co Ltd in the optoelectronic market. Enovis Corp has a strong product portfolio and offers a wide range of optoelectronic products and services to its customers. The company has a strong R&D team and a state-of-the-art manufacturing facility. Enovis Corp is committed to providing the best products and services to its customers and has a strong customer base. The company has a strong brand and is well-positioned in the optoelectronic market.
– Beyond Medical Technologies Inc ($OTCPK:DOCKF)
The company’s market cap is 576.96k as of 2022 and its ROE is -135.24%. The company is engaged in the development, manufacture and sale of medical devices and supplies.
– Hefei Meyer Optoelectronic Technology Inc ($SZSE:002690)
Hefei Meyer Optoelectronic Technology Inc is a Chinese company that manufactures optoelectronic products. Its products are used in a variety of industries, including telecommunications, automotive, and consumer electronics. The company has a market cap of 22.2B as of 2022 and a return on equity of 16.74%.
– Optorun Co Ltd ($TSE:6235)
Optorun Co Ltd is a Japanese company that manufactures and sells optical products. The company has a market cap of 89.2 billion as of 2022 and a return on equity of 12.09%. The company’s products include lenses, cameras, and other optical products.
Summary
Enovis Corp is a growing technology company with an impressive track record of success. In 2023, Thrivent Financial for Lutherans invested $39.24 million in the company, signaling their confidence in Enovis’s potential. Analysts have been generally positive on the company’s prospects, noting its strong financial position and growth prospects. Enovis has a well-diversified business model and the ability to quickly adapt to changing market conditions.
The company has demonstrated expertise in a number of industries, including automation, manufacturing and consumer services. The investment could potentially provide returns to shareholders if Enovis continues to execute well and capitalize on its strengths. Investors should keep an eye on the company’s progress and performance over the coming months as it looks to capitalize on its potential.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
